Fig. 3From: Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver diseaseThe comparison of mean plasma concentration-time curves of MCS and mangiferin after multiple oral administrations in dosage of 240 mg/kgBack to article page
